-
1
-
2
Self-delivering RNAi immunotherapeutic PH-762 silences PD-1 to generate local and abscopal antitumor efficacy
Published 2024-12-01Subjects: “…PD-1 inhibition…”
Get full text
Article -
3
Severe pemphigus vulgaris and cervical carcinoma treated with anti PD1 antibody pembrolizumab: A therapeutic dilemma?
Published 2025-03-01Subjects: Get full text
Article -
4
First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors
Published 2019-12-01Subjects: Get full text
Article -
5
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer
Published 2023-09-01Subjects: Get full text
Article -
6
Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma
Published 2021-04-01Subjects: Get full text
Article -
7
Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives
Published 2025-01-01Subjects: Get full text
Article -
8
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation
Published 2024-04-01Subjects: Get full text
Article -
9